• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎时的发作:来自 WIN-R 试验的观察结果。

Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial.

机构信息

Division of Gastroenterology, Aga Khan university, Karachi, Pakistan.

出版信息

J Clin Gastroenterol. 2011 Mar;45(3):286-92. doi: 10.1097/MCG.0b013e3181f656fb.

DOI:10.1097/MCG.0b013e3181f656fb
PMID:20930643
Abstract

BACKGROUND

Seizures are reported as an uncommon side effect of interferon therapy.

AIM

To determine the frequency and presentation of seizures occurring during pegylated interferon-α (PEG-IFNα) and ribavirin therapy for chronic hepatitis C.

METHODS

Patients were identified using data from the WIN-R trial database, a US multicenter study comparing fixed (800 mg) versus weight-based (800 to 1400 mg) daily dosing of ribavirin in combination with PEG-IFNα-2b (1.5 μg/kg/wk).

RESULTS

Of the 4913 enrolled patients, 8 (0.16%) had a seizure. Three patients had a grand mal seizure and the seizure type was unknown in 5 patients. At the time of seizure, 6 patients were taking antidepressants (including 3 on bupropion), 1 was hyponatremic, and 1 had consumed a significant amount of alcohol. One patient had a history of seizures. Neuroimaging and electroencephalographic studies were negative. Antiepileptic medications were continued in the patient with a history of seizures and initiated in 1 patient. PEG-IFNα-2b plus ribavirin therapy was continued in 2 patients following seizure and neither experienced a recurrent seizure.

CONCLUSIONS

Seizures occur infrequently in patients receiving PEG-IFNα-2b plus ribavirin, and appear to be associated with other risk factors including antidepressant use.

摘要

背景

癫痫发作是干扰素治疗的一种罕见副作用。

目的

确定聚乙二醇干扰素-α(PEG-IFNα)和利巴韦林治疗慢性丙型肝炎期间发生癫痫的频率和表现。

方法

使用来自 WIN-R 试验数据库的数据识别患者,这是一项美国多中心研究,比较了 PEG-IFNα-2b(1.5 μg/kg/周)联合利巴韦林固定剂量(800mg)与体重剂量(800-1400mg)每日给药的疗效。

结果

在 4913 名入组患者中,有 8 名(0.16%)发生了癫痫。3 名患者出现大发作,5 名患者的癫痫类型未知。在癫痫发作时,6 名患者正在服用抗抑郁药(包括 3 名服用安非他酮),1 名患者低钠血症,1 名患者大量饮酒。1 名患者有癫痫发作病史。神经影像学和脑电图研究均为阴性。在有癫痫发作病史的患者中继续使用抗癫痫药物,在 1 名患者中开始使用。在癫痫发作后,2 名患者继续接受 PEG-IFNα-2b 联合利巴韦林治疗,均未再次发生癫痫发作。

结论

在接受 PEG-IFNα-2b 联合利巴韦林治疗的患者中,癫痫发作并不常见,似乎与其他危险因素有关,包括抗抑郁药的使用。

相似文献

1
Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial.聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎时的发作:来自 WIN-R 试验的观察结果。
J Clin Gastroenterol. 2011 Mar;45(3):286-92. doi: 10.1097/MCG.0b013e3181f656fb.
2
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label study.聚乙二醇干扰素 α-2b 联合利巴韦林治疗基因型 1 和 4 慢性丙型肝炎患者的前瞻性、随机、多中心、开放性研究。
Clin Gastroenterol Hepatol. 2010 Jan;8(1):66-71.e1. doi: 10.1016/j.cgh.2009.08.036. Epub 2009 Sep 10.
3
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.聚乙二醇化干扰素α-2a或α-2b联合利巴韦林治疗慢性丙型肝炎期间中性粒细胞减少症和感染的发生率。
Infection. 2008 Jun;36(3):250-5. doi: 10.1007/s15010-007-7132-6. Epub 2008 May 3.
4
Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.聚乙二醇干扰素α-2a(40KD)联合利巴韦林治疗日本慢性丙型肝炎患者。
J Gastroenterol Hepatol. 2007 May;22(5):645-52. doi: 10.1111/j.1440-1746.2007.04834.x.
5
Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study.聚乙二醇干扰素α-2a与聚乙二醇干扰素α-2b治疗丙型肝炎病毒(HCV)慢性活动性肝炎无应答者的一项初步研究。
J Interferon Cytokine Res. 2008 Oct;28(10):623-9. doi: 10.1089/jir.2007.0116.
6
Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.慢性丙型肝炎患者接受聚乙二醇干扰素和利巴韦林抗病毒治疗期间的甲状腺功能及超声形态学变化
J Viral Hepat. 2009 Mar;16(3):168-77. doi: 10.1111/j.1365-2893.2008.01059.x. Epub 2008 Oct 17.
7
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.在一项慢性丙型肝炎病毒基因型 1 患者的随机试验中,阿比干扰素 Alfa-2b 并不逊于聚乙二醇干扰素-α。
Gastroenterology. 2010 Oct;139(4):1257-66. doi: 10.1053/j.gastro.2010.06.066. Epub 2010 Jun 27.
8
Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.患者摘要。聚乙二醇化干扰素联合或不联合利巴韦林用于接受血液透析的丙型肝炎患者。
Ann Intern Med. 2013 Dec 3;159(11):I-14. doi: 10.7326/0003-4819-159-11-201312030-00001.
9
Therapy of chronic hepatitis C with PEG-IFN α-2b plus ribavirin in patients with genotype 2 or 3: 16 versus 24 weeks, clinical outcome and direct cost analyses.聚乙二醇干扰素α-2b联合利巴韦林治疗基因2型或3型慢性丙型肝炎患者:16周与24周对比,临床结局及直接成本分析
Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1396-401. doi: 10.1097/MEG.0b013e328362dc22.
10
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.评价聚乙二醇干扰素 α-2b 和利巴韦林治疗慢性丙型肝炎病毒感染提前停药的不良影响:来自九州大学肝病研究的结果。
J Gastroenterol Hepatol. 2012 Jul;27(7):1233-40. doi: 10.1111/j.1440-1746.2011.06965.x.

引用本文的文献

1
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.新型冠状病毒肺炎(COVID-19)患者中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的神经学后果及治疗引起的神经精神不良事件并发:探索未知领域
Front Mol Biosci. 2021 Feb 18;8:627723. doi: 10.3389/fmolb.2021.627723. eCollection 2021.
2
Psychopharmacology of COVID-19.新型冠状病毒肺炎的精神药理学。
Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18.
3
A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges.
巴基斯坦丙型肝炎病毒患者治疗反应率的系统评价:当前前景与未来挑战
Medicine (Baltimore). 2016 Dec;95(50):e5327. doi: 10.1097/MD.0000000000005327.
4
Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease.巯嘌呤治疗一名患有眼眶和颅内罗萨伊-多夫曼病的成年男性
Case Rep Neurol Med. 2016;2016:1030478. doi: 10.1155/2016/1030478. Epub 2016 Oct 20.
5
Bupropion for interferon-alpha-induced depression in patients with hepatitis C viral infection: an open-label study.盐酸安非他酮治疗丙型肝炎病毒感染患者干扰素-α诱导的抑郁:一项开放标签研究。
Psychiatry Investig. 2015 Jan;12(1):142-5. doi: 10.4306/pi.2015.12.1.142. Epub 2015 Jan 12.